Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes

Molecular Genetics and Metabolism

Volumn 68, Issue 4, 1999, Pages 455-460

  Shimoyama, Rie K ^a   Seto, Shiro ^a,b   Mori, Chuzo ^a,c  

^a SHIMANE UNIVERSITY   (Japan)

^b Kishiwada City Hospital   (Japan)

^c Kyoto Bunkyo University   (Japan)

Author keywords

Adenosine deaminase deficiency; DNA damage; Toxicity of deoxyadenosine

Indexed keywords

ADENOSINE DEAMINASE; CELL DNA; CYCLOHEXIMIDE; DEOXYADENOSINE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE TRIPHOSPHATE; NUCLEOSIDE DERIVATIVE; PENTOSTATIN; THYMIDINE TRIPHOSPHATE;

ARTICLE; CELL ACTIVITY; CELL LEVEL; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DNA REPAIR; DNA STRAND BREAKAGE; DNA SYNTHESIS; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; INCUBATION TIME; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0033398168     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2937     Document Type: Article

References (31)

1. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Lancet II:1067-1069, 1972.
2. Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, Kurtzberg J, Markert ML, Kobayashi RH, Kobayashi AL, Abuchowski A. N Engl J Med 316:589-596, 1987.
3. Culver KW, Anderson WF, Blaese RM. Hum Gene Ther 2:107-109, 1991.
4. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chian gY, Tolsyshev P. Science 270:475-480, 1995.
5. Blaese RM, Culver KW, Chang L, Anderson WF, Mullen C, Neinheyuis A, Carter CS, Dunbar C, Leitman S, Berger M. Hum Gene Ther 4:521-527, 1993.
6. Ullman B, Gudas LJ, Cohen A, Martin DW Jr. Cell 14:365-375, 1978.
7. Hershfield MS, Mitchell MS. In The Metabolic and Molecular Basis of Inherited Disease, New York: McGraw-Hill, Vol 2, pp 1752-1768, 1995.
8. Hirshhhorn R. Pediatr Res 33:35s-41s, 1993.
9. Greer WL, Kaplan JG. Biochem Biophys Res Commun 122: 366-372, 1984.
10. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA. J Clin Invest 75:377-383, 1894.
11. Seto S, Carrera CJ, Wasson DB, Carson DA. J Immunol 136:2839-2843, 1986.
12. Birnboim HC, Jevcak JJ. Cancer Res 41:1889-1892, 1981.
13. Leeds JM, Slabaugh MB, Mathews CK. Mol Cell Biol 5:3443-3450, 1985.
14. Kufe DW, Major PP. Med Pediatr Oncol Suppl 1:49-67, 1982.
15. Wood RD, Shivji MKK. Carcinogenesis (London) 50:605-610, 1997.
16. Creissen D, Shall S. Nature 296:271-272, 1982.
17. Rosen JE, Schluter G, Williams GM. Toxicol Appl Pharmacol 140:254-263, 1996.
18. Cattan AR, Levett D, Douglas EA, Middleton PG, Taylor PR. J Clin Pathol 49:848-852, 1996.
19. Kubota M, Usami I, Watanabe K, Sawada M, Kataoka A, Koishi S, Lin YW, Akiyama Y, Furusho K. Exp Cell Res 235:138-144, 1997.
20. Brox L, Pollock A, Ng E, Belch A. Cancer Res 44:934-937, 1984.
21. Lamballe F, Prise P-YL, Gall EL, David J-C. Leukemia 3:97-103, 1989.
22. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, Wataya Y. J Biol Chem 262:8235-8241, 1987.
23. Munch-Petersen B, Tyrsted G, Dupont B. Exp Cell Res 79: 249-256, 1973.
24. Tyrsted G. Exp Cell Res 91:429-440, 1975.
25. Cohen A, Barankiewicz J, Lederman HM, Gelfand EW. J Biol Chem 258:12334-12340, 1983.
26. Kefford RF, Fox RM. Cancer Res 42:324-330, 1982.
27. Cohen A, Thompson E. Cancer Res 46:1585-1588, 1986.
28. Reichard P. Annu Rev. Biochem 57:349-374, 1988.
29. Jones M. Annu Rev Biochem 49:253-258, 1980.
30. Kunz BA. Mutat Res 200:133-147, 1988.
31. Gangi-Peterson L, Sorscher DH, Reynolds JW, Kepler TB, Mitchell BS. J Clin Invest 103:833-841, 1999.